Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.43 USD | -0.73% | -2.96% | -8.35% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.35% | 18.05B | |
-4.82% | 182B | |
+1.38% | 111B | |
-2.82% | 68.48B | |
+0.69% | 49.69B | |
+8.54% | 44.46B | |
+2.33% | 40.67B | |
+20.50% | 31.22B | |
+1.72% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Transcript : Baxter International Inc. Presents at 2022 Wells Fargo Healthcare Conference, Sep-07-2022 10